首页> 外文期刊>Diabetes >Altered Skeletal Muscle Iipase Expression and Activity Contribute to Insulin Resistance in Humans
【24h】

Altered Skeletal Muscle Iipase Expression and Activity Contribute to Insulin Resistance in Humans

机译:骨骼肌脂酶表达和活性的改变有助于人类的胰岛素抵抗

获取原文
获取原文并翻译 | 示例
       

摘要

OBJECTIVE—Insulin resistance is associated with elevated content of skeletal muscle lipids, including triacylglycerols (TAGs) and diacylglycerols (DAGs). DAGs are by-products of lipolysis consecutive to TAG hydrolysis by adipose triglyceride Iipase (ATGL) and are subsequently hydrolyzed by hormone-sensitive lipase (HSL). We hypothesized that an imbalance of ATGL relative to HSL (expression or activity) may contribute to DAG accumulation and insulin resistance. RESEARCH DESIGN AND METHODS—We first measured bpase expression in vastus lateralis biopsies of young lean (n = 9), young obese (n = 9), and obese-matched type 2 diabetic (n = 8) subjects. We next investigated in vitro in human primary myotubes the impact of altered lipase expression/activity on lipid content and insulin signaling. RESULTS—Muscle ATGL protein was negatively associated with whole-body insulin sensitivity in our population (r = -0.55, P = 0.005), whereas muscle HSL protein was reduced in obese subjects. We next showed that adenovirus-mediated ATGL over-expression in human primary myotubes induced DAG and ceramide accumulation. ATGL overexpression reduced insulin-stimulated glycogen synthesis (—30%, P < 0.05) and disrupted insulin signaling at SerllOl of the insulin receptor substrate-1 and downstream Akt activation at Ser473. These defects were fully rescued by nonselective protein kinase C inhibition or concomitant HSL overexpression to restore a proper lipolytic balance. We show that selective HSL inhibition induces DAG accumulation and insulin resistance. CONCLUSIONS—Altogether, the data indicate that altered ATGL and HSL expression in skeletal muscle could promote DAG accumulation and disrupt insulin signaling and action. Targeting skeletal muscle Upases may constitute an interesting strategy to improve insulin sensitivity in obesity and type 2 diabetes. Diabetes 60:1734-1742, 2011
机译:目的-胰岛素抵抗与骨骼肌脂质(包括三酰基甘油(TAG)和二酰基甘油(DAG))的含量升高有关。 DAG是脂肪分解的副产物,其被脂肪甘油三酸酯脂肪酶(ATGL)进行TAG水解,随后被激素敏感性脂肪酶(HSL)水解。我们假设ATGL相对于HSL的失衡(表达或活性)可能导致DAG积累和胰岛素抵抗。研究设计和方法—我们首先在年轻的瘦小者(n = 9),年轻的肥胖(n = 9)和肥胖匹配的2型糖尿病(n = 8)受试者的股外侧外侧活检中测量了bpase的表达。接下来,我们在体外研究人原代肌管中脂肪酶表达/活性改变对脂质含量和胰岛素信号传导的影响。结果—在我们的人群中,肌肉ATGL蛋白与全身胰岛素敏感性呈负相关(r = -0.55,P = 0.005),而肥胖受试者的肌肉HSL蛋白降低。接下来,我们显示在人原代肌管中腺病毒介导的ATGL过度表达会诱导DAG和神经酰胺蓄积。 ATGL的过表达减少了胰岛素刺激的糖原合成(-30%,P <0.05),并破坏了胰岛素受体底物1的Ser101的胰岛素信号传导和Ser473的下游Akt激活。这些缺陷通过非选择性蛋白激酶C抑制或伴随的HSL过表达得以完全挽救,以恢复适当的脂解平衡。我们表明选择性HSL抑制诱导DAG积累和胰岛素抵抗。结论总而言之,数据表明,骨骼肌中ATGL和HSL表达的改变可能促进DAG的积累并破坏胰岛素的信号传导和作用。靶向骨骼肌Upases可能构成一种有趣的策略,以提高肥胖症和2型糖尿病患者的胰岛素敏感性。糖尿病60:1734-1742,2011

著录项

  • 来源
    《Diabetes》 |2011年第6期|p.1734-1742|共9页
  • 作者单位

    INSERM, U1048, Obesity Research Laboratory, Institute of Metabolicand Cardiovascular Diseases (I2MC), Toulouse, France,Paul SabatierUniversity, University of Toulouse, Toulouse, France;

    INSERM, U1048, Obesity Research Laboratory, Institute of Metabolicand Cardiovascular Diseases (I2MC), Toulouse, France,Paul SabatierUniversity, University of Toulouse, Toulouse, France;

    INSERM, U1048, Obesity Research Laboratory, Institute of Metabolicand Cardiovascular Diseases (I2MC), Toulouse, France,Paul SabatierUniversity, University of Toulouse, Toulouse, France;

    Institute of Clin-ical Chemistry, University of Regensburg, Regensburg, Germany;

    Institute of Clin-ical Chemistry, University of Regensburg, Regensburg, Germany;

    De-partment of Pharmaceutical Biosciences, School of Pharmacy, University ofOslo, Oslo, Norway;

    Translational Research Institute for Metabolismand Diabetes and the Burnham Institute, Florida Hospital, Winter Park,Florida;

    INSERM, U1048, Obesity Research Laboratory, Institute of Metabolicand Cardiovascular Diseases (I2MC), Toulouse, France,Paul SabatierUniversity, University of Toulouse, Toulouse, France,Centre Hospitalier Universitaire de Toulouse, Biochemis-try Laboratory, Biology Institute of Purpan, Toulouse, France;

    INSERM, U1048, Obesity Research Laboratory, Institute of Metabolicand Cardiovascular Diseases (I2MC), Toulouse, France,Paul SabatierUniversity, University of Toulouse, Toulouse, France;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 03:46:34

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号